Neuroendocrine hyperplasia
Overview of neuroendocrine hyperplasia
Classification |
|
---|---|
External resources |
|
Neuroendocrine Hyperplasia[edit | edit source]
Neuroendocrine hyperplasia is a condition characterized by an increase in the number of neuroendocrine cells within a tissue. This condition can occur in various organs, but it is most commonly associated with the lungs, where it is known as diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH).
Pathophysiology[edit | edit source]
Neuroendocrine cells are specialized cells that release hormones into the blood in response to a signal from the nervous system. In neuroendocrine hyperplasia, there is an abnormal proliferation of these cells. This can lead to an overproduction of hormones and other substances, which may cause a variety of symptoms depending on the location and extent of the hyperplasia.
Clinical Presentation[edit | edit source]
Patients with neuroendocrine hyperplasia may present with a range of symptoms. In the case of pulmonary involvement, symptoms can include chronic cough, wheezing, and shortness of breath. These symptoms are often similar to those of other respiratory conditions, which can make diagnosis challenging.
Diagnosis[edit | edit source]
The diagnosis of neuroendocrine hyperplasia typically involves imaging studies, such as computed tomography (CT) scans or magnetic resonance imaging (MRI), to identify areas of increased cell proliferation. A biopsy may be performed to confirm the diagnosis by examining the tissue under a microscope.
Treatment[edit | edit source]
Treatment options for neuroendocrine hyperplasia depend on the severity and location of the condition. In some cases, surgical removal of the affected tissue may be necessary. Medications that inhibit hormone production or block hormone receptors may also be used to manage symptoms.
Prognosis[edit | edit source]
The prognosis for individuals with neuroendocrine hyperplasia varies. In cases where the condition is localized and treated effectively, the outlook can be positive. However, if the hyperplasia is widespread or associated with other complications, the prognosis may be more guarded.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD